Integrating augmented reality navigation into conventional frame-based stereotactic brain biopsy procedures proved technically feasible in a prospective single-center pilot investigation. The clinical study evaluated the combination of holographic guidance with established stereotactic methods in ten adult patients presenting with intracranial lesions. Standard stereotactic brain biopsies typically lack intraoperative visual control during needle advancement, prompting researchers to assess whether holographic overlays could supply real-time tracking.
The study protocol paired standard surgical workflow with augmented reality equipment to test needle visualization. Surgical planning began with the Cosman-Roberts-Wells stereotactic frame, intraoperative computed tomography imaging, and preoperative magnetic resonance imaging coordinated through NeuroSight Arc software. Simultaneously, investigators utilized Medgital software running on a Microsoft HoloLens 2 headset to project a real-time hologram depicting the patient’s head, the intracranial lesion, and the planned biopsy path.
To maintain continuous visual monitoring of the surgical instrument, the operative team attached a passive tracker directly to the biopsy needle. This tracking configuration allowed the HoloLens 2 headset and Medgital platform to render a holographic representation of the needle as it moved along the chosen trajectory. The clinical team systematically monitored core trial endpoints, focusing on technical feasibility, overall registration time, spatial navigation error, diagnostic yield, and intraoperative complications.
Augmented reality navigation achieved a technical feasibility rate of one hundred percent, functioning successfully across all ten enrolled patients. Registration procedures required an average duration of 79 ± 27 seconds to align the virtual models with the operative environment. Quantitative trajectory assessments revealed a mean navigation error of 2.21 ± 0.67 millimeters relative to the standard stereotactic plan, indicating acceptable spatial precision during clinical deployment.
Diagnostic tissue sampling yielded definitive histological diagnoses in all ten surgical cases, requiring a mean of 2.4 needle passes per patient. Safety assessments documented no hemorrhagic complications and zero procedure-related mortality among the cohort. These preliminary clinical findings suggest that integrating augmented reality navigation into traditional frame-based biopsy workflows provides a safe, rapid, and accurate visual complement to standard stereotactic techniques.
Despite the successful demonstration of holographic needle tracking, the reported evidence remains limited to a single-center pilot series of ten adult participants.
Subject of Research: Augmented reality navigation in frame-based stereotactic brain biopsy
Article Title: Application of augmented reality in frame-based stereotactic brain biopsy: a case series feasibility study
Article References: Konovalov, A. N., Bykanov, A. E., Okishev, D. N., Maryashev, S. A., Bezbabicheva, T. S., Trubnikov, E. A., Tursunkulov, S. G., Artemyev, A. A., Erokhin, I. A., Sergeeva, S. S., Starostenko, D. A., Knyazev, A. V., Ivanov, V. M., Smirnov, A. V., Strelkov, S. V., Pronin, I. N., Pavlova, G. V., Grachev, N. S., Pitskhelauri, D. I., & Eliava, S. S. (2026). Application of augmented reality in frame-based stereotactic brain biopsy: a case series feasibility study. Journal of Neuro-Oncology, 180(3), Article 64. https://doi.org/10.1007/s11060-026-05886-9
Image Credits: AI Generated
DOI: 10.1007/s11060-026-05886-9
Keywords: augmented reality, stereotactic biopsy, brain biopsy, Microsoft HoloLens 2, Medgital, Cosman-Roberts-Wells, frame-based biopsy, intraoperative CT, preoperative MRI, NeuroSight Arc, holographic navigation, needle trajectory, pilot study, intracranial lesions, surgical navigation
News Source: Cassandra Pierce. (November 20, 2026). Augmented Reality Navigation Shows Feasibility in Pilot Brain Biopsy Study. Scienmag.



